Elliot S Barnathan
8PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 02, 2024
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial.Zhong Yuan, Bennett Levitan, Hsiaowei Deng
|Nov 23, 2023
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials.Judith Hsia, Alex C Spyropoulos, Gregory Piazza
|May 08, 2023
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.Gregory Piazza, Alex C Spyropoulos, Judith Hsia
|Oct 27, 2022
Extended Thromboprophylaxis in Hospitalized Patients with Heart Failure: A Post Hoc Analysis of the MAGELLAN Study.Alex C Spyropoulos, Gary E Raskob, Theodore E Spiro
|Oct 07, 2022
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.Gary E Raskob, Walter Ageno, Gregory Albers
|Sep 01, 2022
Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial.Alex C Spyropoulos, Mark Goldin, Walter Ageno
Pageof 2
Frequent Collaborators
7 joint publications
Alex C Spyropoulos
3 joint publications
Gary E Raskob
2 joint publications
Walter Ageno
2 joint publications
Gregory W Albers
2 joint publications
Jonathan L Halperin
2 joint publications
Gregory Maynard
2 joint publications
Philippe Gabriel Steg
2 joint publications
Marc P Bonaca
2 joint publications
Judith Hsia
1 joint publications
Alexander T Cohen
